IP In Systems Biology
Patenting your personalised medicine innovations to change the concept of biomedical care.
In the Chair:
Dr. Kári Stefánsson
Hear from your eminent Speaker Panel:
Jay Z. Zhang
Dr. Gerald V. Dahling
Thomas Malone Ph.D.
Stephen K. Boyer Ph.D.
Elizabeth A. Doherty, Ph.D.
Peter Horn Mĝller, Ph.D.
Nicka Kirstejn Johansen M.Sc.
We are facing a paradigm shift in the global life science industry today. Personalised medicines allow biotech and pharmaceutical companies to deliver customised drugs or treatment options that match each individual's genetic make-up. To be at the forefront your company needs to master the IP strategies successfully in an emerging field of pharmaceutics.
The driving force behind this radical transformation is the mapping of the human genome and its combination with proteomics in the human body.
It is important to develop an IP strategy focusing on your personalised medicine innovations where genomic relationships are being used to customise a drug for specific target diseases. The key to success is the combination. Narrow claims protect your biotech invention and will successfully exclude your competitors to exploit the claimed genomic relationship in your patents.
This international flagship event will present the IP leaders within personalised medicine providing your company with an IP platform to protect your personalised medicine innovations in the era of post-genomics. Our high level speaker panel will guide you through the steps required to protect your company's most valuable assets, the patents.
This conference will tackle key issues such as:
Target audience and Job Titles:
Presidents, Chief Executive Officers, Chief IP Counsels, Chief Scientific Officers, Vice Presidents, Directors and Heads of:
Official Hotel & Airline: